Finnish Institute for Health and Welfare: Hepatitis C spreads in Finland primarily through drug use
The Finnish Institute for Health and Welfare (THL) has published new information regarding the situation of hepatitis C infections in Finland. According to the agency, the majority of hepatitis C cases identified in our country are linked to intravenous drug use.
Hepatitis C is a virus that causes liver inflammation and is most commonly transmitted through blood. According to THL, preventing infections is important, as a long-term infection can cause serious damage to a person's liver, such as cirrhosis or cancer.
Authorities emphasize that reducing infections requires targeted measures. The most important ways to prevent the spread of the virus are the availability of clean injection equipment and counseling that helps users reduce risks in their daily lives.
In Finland, the healthcare system strives to identify infections as early as possible. Early diagnosis plays a significant role, as modern medical treatments are highly effective and can permanently cure most patients.
THL continues to monitor the situation and reminds that hepatitis C is a public health challenge, the management of which requires ongoing cooperation between social and health services. The goal is to reduce infections and improve access to care for high-risk groups.